Know Cancer

or
forgot password
  • cancer clinical trials in rochester, NY

  • Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
    Dermatology Associates of Rochester
    Rochester, New York 14623
    Actinic Keratosis
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Neuroblastoma
    Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Drug/Agent Toxicity by Tissue/Organ, Multiple Myeloma and Plasma Cell Neoplasm
    A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
    University of Rochester
    Rochester, New York 14642
    Thrombosis, Cancer, Pulmonary Embolism
    Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients
    University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma, Non-Hodgkin, Multiple Myeloma
    S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Gastric Cancer
    High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Sarcoma
    Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
    University of Rochester Cancer Center
    Rochester, New York 14642
    Peripheral T-cell Lymphoma
    Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease
    University of Rochester Medical Center
    Rochester, New York 14642
    Myelogenous Leukemia, Acute, Myelodysplastic Syndromes
    Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults
    Univ. of Rochester ACTG CRS

    Trial Locations
    Univ. of Rochester ACTG CRS
    AIDS Care CRS
    HIV Infections
    Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML
    University of Rochester
    Rochester, New York 14642
    Acute Myelogenous Leukemia
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    University of Rochester
    Rochester, New York 14642
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    TroVax Renal Immunotherapy Survival Trial
    Pluta Cancer Centre
    Rochester, New York 14623
    Clear Cell Renal Carcinoma
    Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer
    University of Rochester Medical Center
    Rochester, New York 14642
    Bladder Neoplasms
    A Study of Abatacept in Patients With Active Crohn's Disease
    U Of Rochester Gastroenterology And Hepatology
    Rochester, New York 14642
    Crohn's Disease
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    University of Rochester Medical Center
    Rochester, New York 14642
    Cytomegalovirus Infections
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    University of Rochester

    Trial Locations
    University of Rochester
    Highland Hospital
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Prostate Cancer
    Assessment and Tracking of Long-term Alefacept Safety
    Dermatology Partners of Western New York
    Rochester, New York 14607
    Psoriasis
    A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
    University of Rochester Medical Center
    Rochester, New York 14642
    Glioblastoma Multiforme, Brain Neoplasms
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Trial of Patient Navigation-Activation
    University of Rochester
    Rochester, New York 14642
    Breast Cancer, Colorectal Cancer
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
    University of Rochester Medical Center
    Rochester, New York 14642
    Multiple Sclerosis, Relapsing-Remitting
    Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma
    University of Rochester Medical Center (James P. Wilmot Cancer Center)
    Rochester, New York 14642
    Non-Hodgkin's Lymphoma
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    University of Rochester Medical Center
    Rochester, New York 14642
    Multiple Sclerosis, Relapsing-Remitting
    Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
    Interlakes Foundation, Inc.
    Rochester, New York 14623
    Non-Hodgkin's Lymphoma
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Interlakes Oncology & Hematology, P.C.
    Rochester, New York 14623
    Metastatic Breast Cancer
    Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma
    University of Rochester Medical Center, Strong Memorial Hospital
    Rochester, New York 10016
    Recurrent Diffuse Pontine Gliomas
    Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients
    University of Rochester MC / James P. Wilmot Cancer Center James P. Wilmot Cancer Center

    Trial Locations
    University of Rochester MC / James P. Wilmot Cancer Center James P. Wilmot Cancer Center
    Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center
    Multiple Myeloma
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    Rochester General Hospital - Lipson Cancer Center
    Rochester, New York 14621
    Non-Small Cell Lung Cancer
    Cognition in the Study of Tamoxifen and Raloxifene
    University of Rochester Cancer Center
    Rochester, New York 14642
    Cognition, Aging
    Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
    Investigational Site Number 840024
    Rochester, New York 14642
    Venous Thromboembolism, Cancer
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    University of Rochester Medical Center
    Rochester, New York 14642
    Myelodysplastic Syndrome (MDS)
    Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
    University of Rochester Medical Center
    Rochester, New York 14642
    Non Small Cell Lung Cancer
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    Interlakes Foundation
    Rochester, New York 14623
    Relapsed Follicular Lymphoma
    Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Head and Neck Cancer
    Safety and Efficacy Study of Switching From Epzicom to Truvada
    AIDS Community Health Center
    Rochester, New York 14604
    HIV Infection
    Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
    University of Rochester Medical Center
    Rochester, New York 14642
    Anaplastic Astrocytoma, Glioblastoma
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    University of Rochester
    Rochester, New York 14642
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    University of Rochester
    Rochester, New York 14642
    Ulcerative Colitis
    RDEA119 and Sorafenib Combination Dose Escalation Study
    James P. Wilmot Cancer Center
    Rochester, New York 14642
    Advanced Cancer
    In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis
    University of Rochester Medical Center
    Rochester, New York 14642
    Skin Cancer, Melanoma, Lentigo Maligna
    Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
    University of Rochester
    Rochester, New York 14642
    Rheumatoid Arthritis
    Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults
    Univ. of Rochester HVTN CRS
    Rochester, New York 14642
    HIV Infections
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    University of Rochester

    Trial Locations
    University of Rochester
    Highland Hospital
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes